Can I perform BCR Repertoire Analysis on archived FFPE samples?

Yes. While FFPE samples often contain fragmented RNA, our specialized extraction and library preparation protocols (using shorter targeted amplicons) allow us to retrieve meaningful BCR repertoire data from clinical archives.

How do you eliminate PCR bias in your high-throughput sequencing?

We utilize Unique Molecular Identifiers (UMIs) and 5' RACE technology. UMIs allow us to collapse PCR duplicates bioinformatically, while 5' RACE ensures that all V-gene segments are amplified equally, regardless of sequence variation.

What is the typical sequencing depth required for BCR Repertoire Analysis?

For general diversity studies, 1-2 million reads per sample is standard. For high-sensitivity applications like MRD monitoring, we may recommend depths of 5-10 million reads to ensure the detection of rare clones.

What is the difference between analyzing BCR at the DNA vs. RNA level?

DNA analysis includes all rearranged B-cells (including non-functional ones) and provides a 1:1 ratio of sequence to cell. RNA analysis captures only expressed receptors and provides insights into the "functional" immune activity, which is generally more relevant for vaccine and drug research.

Do you provide assistance with the interpretation of the bioinformatics report?

Absolutely. Every project includes a consultation session with our PhD-level immunology experts to help you understand the clinical and biological significance of your BCR Repertoire NGS sequencing data.

Can you sequence the constant regions to determine the antibody isotype?

Yes. Our primers are designed to cover the transition into the constant region, allowing us to accurately identify IgM, IgD, IgG1-4, IgA1-2, and IgE isotypes.

Is your BCR Repertoire Analysis platform compatible with non-human species?

Yes, we have extensive databases and primer sets for mice, rats, rabbits, llamas/alpacas (VHH), and non-human primates.

How do you ensure the privacy and security of my genomic data?

Creative Biolabs adheres to strict data protection protocols. All sequencing data is stored on secure, encrypted servers, and we offer non-disclosure agreements (NDAs) to protect your intellectual property.

Advanced BCR Repertoire Analysis Services

Background Workflow Application Advantage Related Service FAQ Online Inquiry

In the modern landscape of biopharmaceutical research and precision medicine, the B-cell receptor (BCR) repertoire represents an untapped reservoir of diagnostic and therapeutic information. As a global leader in immunology and antibody engineering, Creative Biolabs provides a comprehensive BCR Repertoire Analysis Solution that leverages cutting-edge high-throughput sequencing (NGS) to provide an unprecedented view of the immune system's adaptive landscape.

Discuss Your Project Today

Understanding the B-cell Receptor (BCR) Repertoire

The B-cell receptor (BCR) is the membrane-bound immunoglobulin molecule that allows a B-cell to detect and respond to specific antigens. The collective diversity of all BCRs within an individual constitutes the B-cell receptor (BCR) repertoire. This repertoire is a dynamic record of an organism's immunological history, reflecting past infections, vaccinations, and the development of autoimmune conditions or malignancies. Through BCR Repertoire Analysis, researchers can track the maturation of B-cells from naive stages to memory or plasma cells. This involves monitoring V(D)J recombination, somatic hypermutation (SHM), and class-switch recombination (CSR). Understanding these processes is critical for:

Antibody discovery and engineering.
Vaccine efficacy assessment.
Minimal Residual Disease (MRD) monitoring in B-cell malignancies.
Immune monitoring in clinical trials.

Fig. 1 Structure of BCR. (OA Literature) Fig. 1 BCR structure.¹

The Creative Biolabs BCR Repertoire Solution Workflow

Our end-to-end service is engineered to ensure data integrity and biological accuracy at every milestone.

Phase I: Sample Optimization and RNA/DNA Extraction

We support a vast array of starting materials, including:

Peripheral Blood Mononuclear Cells (PBMCs)
Spleen, Lymph Node, and Bone Marrow tissues
Antigen-specific sorted B-cell populations
Fixed tissues (FFPE) and biopsies

For the most accurate B-cell receptor (BCR) repertoire analysis, we generally recommend RNA as the starting template. This captures the active, functional repertoire and avoids the interference of non-functional pseudogenes and large intronic regions present in genomic DNA.

Phase II: Advanced Library Preparation

The quality of BCR Repertoire Sequencing is determined by the library. We utilize two sophisticated strategies:

5' RACE (Rapid Amplification of cDNA Ends): This "unbiased" approach uses a universal forward primer attached to the 5' end of the cDNA, ensuring that all V-gene families are amplified with equal efficiency. This eliminates the "primer bias" often seen in multiplex PCR.
Unique Molecular Identifiers (UMIs): We integrate random barcoding (UMIs) at the single-molecule level. This allows our bioinformaticians to distinguish between PCR-induced duplicates and true clonal expansion, providing an absolute quantification of the BCR repertoire.

Phase III: High-Throughput Sequencing Execution

Using our advanced high-throughput sequencing platform, we generate massive datasets with high Q30 scores.

Phase IV: Sophisticated Bioinformatics & Data Interpretation

Data is processed through our proprietary pipeline, which includes:

V(D)J Germline Mapping: For precise segment identification.
Clonotype Clustering: Defining clones based on CDR3 sequence identity and V/J usage.
Isotype Classification: Identifying the constant region to determine if the clone belongs to IgM, IgG, IgA, IgE, or IgD.
Diversity Quantification: Applying mathematical models to measure repertoire richness and evenness.

Key Features and Advantages of Our Service

Ultra-High Sensitivity: Detect rare B-cell clones at a frequency of 1 in 1,000,000.
Unbiased Amplification: 5' RACE technology ensures that no specific BCR sequence is "missed" due to primer mismatch.
Comprehensive Isotype Coverage: Simultaneous detection of IgM, IgD, IgG (1-4), IgA (1-2), and IgE.
Full-Length Sequencing: Capture the entire Variable region for precise antibody modeling.
Expert Consultation: Our PhD-level scientists assist in experimental design and data interpretation.

Fig. 2 Sequence analysis of BCR repertoire. (OA Literature) Fig. 2 BCR repertoire sequence analysis.¹

Applications of BCR Repertoire Analysis

Antibody Discovery and Development

By analyzing the B-cell receptor (BCR) repertoire of immunized animals or convalescent patients, we can rapidly identify high-affinity lead candidates. The pairing information from our single-cell high-throughput sequencing platform accelerates the transition from "sequence" to "synthetic antibody."

Vaccine Research

BCR Repertoire Sequencing allows researchers to measure the "breadth" and "depth" of the immune response elicited by a vaccine candidate. We track the emergence of broadly neutralizing antibodies (bNAbs) and the establishment of long-lived memory B-cell pools.

Oncology and Immunotherapy

In B-cell lymphomas and leukemias, the BCR repertoire becomes highly polarized. Our NGS sequencing solutions provide sensitive monitoring for Minimal Residual Disease (MRD) and the evaluation of B-cell reconstitution following CAR-T therapy or bone marrow transplantation.

Autoimmune Disease Research

Identify pathogenic B-cell clones in diseases like Rheumatoid Arthritis or Multiple Sclerosis. Understanding the BCR repertoire dynamics helps in identifying potential biomarkers for disease progression and therapeutic response.

Why Creative Biolabs Stands Out

For over 20 years, Creative Biolabs has been synonymous with excellence in antibody research. Our BCR Repertoire Analysis services are built on a foundation of:

Precision Molecular Biology: Optimized PCR and UMI protocols to ensure "what you sequence is what was in the sample."
Scalable High-Throughput Platforms: Capacity to handle hundreds of samples with consistent quality.
Customizable Bioinformatics: We don't just use standard tools; we build custom pipelines to answer your specific biological questions.
Global Footprint: Supporting researchers in over 50 countries with dedicated project management.

Explore Our Comprehensive Services

To provide a full-spectrum BCR Repertoire Solution, Creative Biolabs offers several interconnected services:

Ready to accelerate your immunology research? Our experts are standing by to discuss your specific B-cell receptor (BCR) repertoire analysis needs.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQs)

Q: Can I perform BCR Repertoire Analysis on archived FFPE samples?
A: Yes. While FFPE samples often contain fragmented RNA, our specialized extraction and library preparation protocols (using shorter targeted amplicons) allow us to retrieve meaningful BCR repertoire data from clinical archives.
Q: How do you eliminate PCR bias in your high-throughput sequencing?
A: We utilize Unique Molecular Identifiers (UMIs) and 5' RACE technology. UMIs allow us to collapse PCR duplicates bioinformatically, while 5' RACE ensures that all V-gene segments are amplified equally, regardless of sequence variation.
Q: What is the typical sequencing depth required for BCR Repertoire Analysis?
A: For general diversity studies, 1-2 million reads per sample is standard. For high-sensitivity applications like MRD monitoring, we may recommend depths of 5-10 million reads to ensure the detection of rare clones.
Q: What is the difference between analyzing BCR at the DNA vs. RNA level?
A: DNA analysis includes all rearranged B-cells (including non-functional ones) and provides a 1:1 ratio of sequence to cell. RNA analysis captures only expressed receptors and provides insights into the "functional" immune activity, which is generally more relevant for vaccine and drug research.
Q: Do you provide assistance with the interpretation of the bioinformatics report?
A: Absolutely. Every project includes a consultation session with our PhD-level immunology experts to help you understand the clinical and biological significance of your BCR Repertoire NGS sequencing data.
Q: Can you sequence the constant regions to determine the antibody isotype?
A: Yes. Our primers are designed to cover the transition into the constant region, allowing us to accurately identify IgM, IgD, IgG1-4, IgA1-2, and IgE isotypes.
Q: Is your BCR Repertoire Analysis platform compatible with non-human species?
A: Yes, we have extensive databases and primer sets for mice, rats, rabbits, llamas/alpacas (VHH), and non-human primates.
Q: How do you ensure the privacy and security of my genomic data?
A: Creative Biolabs adheres to strict data protection protocols. All sequencing data is stored on secure, encrypted servers, and we offer non-disclosure agreements (NDAs) to protect your intellectual property.

References

Xu, Zichang, et al. "Advances in antibody discovery from human BCR repertoires." Frontiers in Bioinformatics 2 (2022): 1044975. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fbinf.2022.1044975

×

Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.